|
FUBP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33860000031783E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.583000E-03 |
| Normal-vs-Stage2 |
6.283600E-03 |
| Normal-vs-Stage3 |
4.05199995778815E-09 |
| Normal-vs-Stage4 |
2.89580004420031E-09 |
| Stage1-vs-Stage2 |
2.879400E-01 |
| Stage1-vs-Stage3 |
8.35210000000863E-05 |
| Stage1-vs-Stage4 |
4.38310000000497E-05 |
| Stage2-vs-Stage3 |
1.515970E-01 |
| Stage2-vs-Stage4 |
9.380000E-02 |
| Stage3-vs-Stage4 |
5.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97690000036665E-07 |
| Normal-vs-AfricanAmerican |
2.482200E-03 |
| Normal-vs-Asian |
7.782600E-01 |
| Caucasian-vs-AfricanAmerican |
7.966800E-01 |
| Caucasian-vs-Asian |
2.146400E-01 |
| AfricanAmerican-vs-Asian |
2.846600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.26099999728535E-09 |
| Normal-vs-Female |
4.941300E-03 |
| Male-vs-Female |
6.634600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.958820E-03 |
| Normal-vs-Age(41-60Yrs) |
1.186000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.23049999967151E-07 |
| Normal-vs-Age(81-100Yrs) |
4.158500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.146800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.751000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.422200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.388190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.800000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.018580E-01 |
| Normal-vs-Grade 2 |
9.578700E-03 |
| Normal-vs-Grade 3 |
5.55190005080419E-09 |
| Normal-vs-Grade 4 |
4.95520291465823E-11 |
| Grade 1-vs-Grade 2 |
2.283500E-02 |
| Grade 1-vs-Grade 3 |
2.08509999999329E-05 |
| Grade 1-vs-Grade 4 |
1.77629999997819E-06 |
| Grade 2-vs-Grade 3 |
3.58890000000667E-05 |
| Grade 2-vs-Grade 4 |
6.45500000007182E-07 |
| Grade 3-vs-Grade 4 |
1.908030E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.079000E-01 |
| Normal-vs-ccB subtype |
3.54949958314421E-10 |
| ccA subtype-vs-ccB subtype |
1.20220000621174E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13849999997073E-06 |
| Normal-vs-N1 |
2.781200E-04 |
| N0-vs-N1 |
2.715400E-01 |
|
|
